Sanofi SA (ADR) (SNY) Stock Faces Lower Risks Forward After Forming Bullish Multiple Top Chart Pattern

November 14, 2017 - By Peter Erickson

The stock of Sanofi SA (ADR) (SNY) shows a multiple tops pattern with $46.34 target or 4.00 % above today’s $44.56 share price. The 6 months chart pattern indicates low risk for the $112.39B company. It was reported on Nov, 14 by Finviz.com. If the $46.34 price target is reached, the company will be worth $4.50 billion more.
Multiple tops are chart patterns with decent performance in a bull market. The failure rate is higher but the average decline is reasonable. Back-tests of such patterns show that the break even failure rate is 10%, the average rise: 19%, the throwback rate: 61% and the percentage of stocks meeting their price targets: 40%.

About 351,787 shares traded. Sanofi SA (ADR) (NYSE:SNY) has risen 26.96% since November 14, 2016 and is uptrending. It has outperformed by 10.26% the S&P500.

Wall Street await Sanofi SA (ADR) (NYSE:SNY) to release earnings on February, 14. Analysts forecast EPS of $0.69, up exactly $0.02 or 2.99 % from 2014’s $0.67 EPS. The expected SNY’s profit could reach $1.74 billion giving the stock 16.14 P/E in the case that $0.69 earnings per share is reported. After posting $1.00 EPS for the previous quarter, Sanofi SA (ADR)’s analysts now forecast -31.00 % negative EPS growth.

Sanofi SA (ADR) (NYSE:SNY) Ratings Coverage

Among 11 analysts covering Sanofi-aventis Sa (NYSE:SNY), 3 have Buy rating, 0 Sell and 8 Hold. Therefore 27% are positive. Sanofi-aventis Sa had 19 analyst reports since October 15, 2015 according to SRatingsIntel. On Monday, November 7 the stock rating was initiated by Goldman Sachs with “Neutral”. On Thursday, October 15 the stock rating was upgraded by Morgan Stanley to “Overweight”. The firm earned “Neutral” rating on Friday, September 23 by Piper Jaffray. The company was maintained on Friday, October 13 by Cowen & Co. The firm has “Mkt Perform” rating given on Monday, November 9 by Bernstein. The rating was downgraded by HSBC on Tuesday, May 3 to “Hold”. JP Morgan upgraded Sanofi SA (ADR) (NYSE:SNY) on Wednesday, April 12 to “Neutral” rating. The stock has “Sell” rating by JP Morgan on Friday, March 31. As per Thursday, May 11, the company rating was downgraded by Berenberg. As per Friday, April 7, the company rating was downgraded by HSBC.

More important recent Sanofi SA (ADR) (NYSE:SNY) news were published by: Investorplace.com which released: “3 Stocks to Watch on Monday: Tesla Inc (TSLA), Sanofi SA (ADR) (SNY) and …” on April 03, 2017, also Investorplace.com published article titled: “5 Reasons Why Sanofi SA (ADR) (SNY) is a Good Stock to Buy Now”, Benzinga.com published: “The Pullback In Sanofi Is A Buying Opportunity, Says Argus” on September 01, 2017. More interesting news about Sanofi SA (ADR) (NYSE:SNY) was released by: Investorplace.com and their article: “Think Sanofi SA (ADR) (SNY) Stock When You Think Big Pharma” with publication date: December 09, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.